Literature DB >> 16652134

Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V.

J Aberle1, I Hopfer, F U Beil, U Seedorf.   

Abstract

OBJECTIVE: To investigate the association of a polymorphism at position 294 (+294T/C) in the Peroxisome Proliferator-activated Receptor delta (PPARdelta) with body mass index (BMI) and the additional role of a gene-to-gene interaction between PPARdelta, PPARalpha and PPARgamma.
DESIGN: An association between genetic variations in PPARdelta, PPARalpha and PPARgamma and indices of obesity and metabolism.
SUBJECTS: A group of 462 moderately obese (mean BMI 28.9+/-7.7) and dyslipidemic, middle-aged (mean age 43.9+/-13.7), Caucasion men and women. MEASUREMENTS: The three most frequent single-nucleotide-polymorphisms (snp) in PPARdelta (+294T/C), PPARalpha (L162V) and PPARgamma (P12A) were genotyped and associated with clinical parameters.
RESULTS: The C allele in PPARdelta was significantly associated with a lower body mass index. Moreover an interaction between the polymorphisms in PPARalpha and PPARdelta on body weight could be demonstrated.
CONCLUSION: Our data provide further evidence for an involvement of PPARdelta in the regulation of BMI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652134     DOI: 10.1038/sj.ijo.0803345

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  19 in total

1.  Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.

Authors:  Raquel Villegas; Scott Williams; Yutang Gao; Qiuyin Cai; Honglan Li; Tom Elasy; Hui Cai; Todd Edwards; Yong-Bing Xiang; Wei Zheng; Jirong Long; Xiao Ou Shu
Journal:  Ann Hum Genet       Date:  2011-09       Impact factor: 1.670

2.  Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.

Authors:  N Grarup; A Albrechtsen; J Ek; K Borch-Johnsen; T Jørgensen; O Schmitz; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2007-04-13       Impact factor: 10.122

Review 3.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 4.  Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

Authors:  Chen Dong; Hui Zhou; Chong Shen; Lu-Gang Yu; Yi Ding; Yong-Hong Zhang; Zhi-Rong Guo
Journal:  World J Diabetes       Date:  2015-05-15

5.  Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice.

Authors:  G Li; C Chen; S D Laing; C Ballard; K C Biju; R L Reddick; R A Clark; S Li
Journal:  Gene Ther       Date:  2015-08-23       Impact factor: 5.250

Review 6.  PPAR delta as a therapeutic target in metabolic disease.

Authors:  Shannon M Reilly; Chih-Hao Lee
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

7.  Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population.

Authors:  Phee-Phee Chia; Sook-Ha Fan; Yee-How Say
Journal:  Ethn Dis       Date:  2015-11-05       Impact factor: 1.847

8.  Analysis on the association between PPARα/γ polymorphisms and lipoprotein(a) in a Chinese Han population.

Authors:  Hui-Jian Xie; Bo Hai; Ming Wu; Qiu Chen; Meng-Meng Liu; Chen Dong; Zhi-Rong Guo
Journal:  Mol Genet Genomics       Date:  2014-06-01       Impact factor: 3.291

9.  Effect of genetic polymorphism +294T/C in peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in a Tunisian population.

Authors:  Khouloud Chehaibi; Mohamed Yahia Hrira; Mustapha Rouis; Mohamed Najah; Imen Jguirim-Souissi; Samir Nouira; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2013-03-20       Impact factor: 3.444

10.  PPAR-delta in Vascular Pathophysiology.

Authors:  Nanping Wang
Journal:  PPAR Res       Date:  2009-01-06       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.